Possibilities of using blood natriuretic peptide levels as biomarkers of morbidity and aging

This brief review examines the prospects for the practical use of natriuretic peptide levels as biomarkers of aging and morbidity. A comparison of discrete and continuous methods for assessing these indicators is made. Their place in the comprehensive diagnostics of acute and chronic heart failure with preserved and reduced ejection fraction and with atrial fibrillation is determined. The prognostic value of natriuretic peptide levels as risk factors for adverse events and death in patients with chronic pathology and in healthy individuals is also discussed.